Cargando…
Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941788/ https://www.ncbi.nlm.nih.gov/pubmed/29739455 http://dx.doi.org/10.1186/s12894-018-0341-8 |
_version_ | 1783321355865817088 |
---|---|
author | Kwon, Young Suk Farber, Nicholas Yu, Ji Woong Rhee, Kevin Han, Christopher Ney, Patrick Hong, Jeong Hee Lee, Paul Gupta, Nikhil Kim, Wun-Jae Kim, Isaac Yi |
author_facet | Kwon, Young Suk Farber, Nicholas Yu, Ji Woong Rhee, Kevin Han, Christopher Ney, Patrick Hong, Jeong Hee Lee, Paul Gupta, Nikhil Kim, Wun-Jae Kim, Isaac Yi |
author_sort | Kwon, Young Suk |
collection | PubMed |
description | BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was performed during a preoperative and postoperative follow-up visits at 7 days and 3, 6, 9, and 12 months. Patients who completely recovered (CR: N = 397) their preoperative stretched PL measured during at least one of their follow-up visits were compared to those with incomplete recovery (IR: N = 131). Recovery patterns were analyzed for both groups and were also compared in regards to demographics, nerve-sparing techniques, prostate size, cardiovascular risk profiles, and phosphodiesterase-5 inhibitor (PDE5i) uses. Logistic regression analyses were performed using age and other relevant clinicopathologic variables to predict PL recovery. RESULTS: 60.2% of the total study population regained their preoperative PL at 12 months. Average percent (length) differences from baseline were − 1.70% (− 0.25 cm) and − 16.42% (− 2.35 cm) in the CR and the IR groups, respectively (p < 0.001). Multivariate logistic regression demonstrated that younger age (OR 0.962; 95%CI 0.931–0.994; p = 0.019), high preoperative erectile function (EF) (OR 1.028; 95%CI 1.001–1.056; p = 0.046), and consistent PDE5i use (OR 1.998; 95%CI 1.166–3.425; p = 0.012) were independent predictors of CR. At 12-month follow up, PL difference for consistent PDE5iusers was statistically different from those who did not use PDE5i consistently (− 3.25%vs. -6.64%; P = 0.001). CONCLUSION: Age, preoperative EF, and consistent use of PDE5i were associated with complete recovery of baseline PL after RP. The therapeutic effect of PDE5i was most pronounced at 12-month visit, suggesting an added benefit with long-term use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-018-0341-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5941788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59417882018-05-14 Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy Kwon, Young Suk Farber, Nicholas Yu, Ji Woong Rhee, Kevin Han, Christopher Ney, Patrick Hong, Jeong Hee Lee, Paul Gupta, Nikhil Kim, Wun-Jae Kim, Isaac Yi BMC Urol Research Article BACKGROUND: Penile length (PL) shortening is an underreported phenomenon following radical prostatectomy (RP) and risk factors are not fully explored. We aimed to describe longitudinal patterns of PL recovery and evaluate factors predicting complete return to baseline PL. METHODS: PL measurement was performed during a preoperative and postoperative follow-up visits at 7 days and 3, 6, 9, and 12 months. Patients who completely recovered (CR: N = 397) their preoperative stretched PL measured during at least one of their follow-up visits were compared to those with incomplete recovery (IR: N = 131). Recovery patterns were analyzed for both groups and were also compared in regards to demographics, nerve-sparing techniques, prostate size, cardiovascular risk profiles, and phosphodiesterase-5 inhibitor (PDE5i) uses. Logistic regression analyses were performed using age and other relevant clinicopathologic variables to predict PL recovery. RESULTS: 60.2% of the total study population regained their preoperative PL at 12 months. Average percent (length) differences from baseline were − 1.70% (− 0.25 cm) and − 16.42% (− 2.35 cm) in the CR and the IR groups, respectively (p < 0.001). Multivariate logistic regression demonstrated that younger age (OR 0.962; 95%CI 0.931–0.994; p = 0.019), high preoperative erectile function (EF) (OR 1.028; 95%CI 1.001–1.056; p = 0.046), and consistent PDE5i use (OR 1.998; 95%CI 1.166–3.425; p = 0.012) were independent predictors of CR. At 12-month follow up, PL difference for consistent PDE5iusers was statistically different from those who did not use PDE5i consistently (− 3.25%vs. -6.64%; P = 0.001). CONCLUSION: Age, preoperative EF, and consistent use of PDE5i were associated with complete recovery of baseline PL after RP. The therapeutic effect of PDE5i was most pronounced at 12-month visit, suggesting an added benefit with long-term use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12894-018-0341-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-09 /pmc/articles/PMC5941788/ /pubmed/29739455 http://dx.doi.org/10.1186/s12894-018-0341-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Kwon, Young Suk Farber, Nicholas Yu, Ji Woong Rhee, Kevin Han, Christopher Ney, Patrick Hong, Jeong Hee Lee, Paul Gupta, Nikhil Kim, Wun-Jae Kim, Isaac Yi Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title | Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title_full | Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title_fullStr | Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title_full_unstemmed | Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title_short | Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
title_sort | longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941788/ https://www.ncbi.nlm.nih.gov/pubmed/29739455 http://dx.doi.org/10.1186/s12894-018-0341-8 |
work_keys_str_mv | AT kwonyoungsuk longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT farbernicholas longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT yujiwoong longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT rheekevin longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT hanchristopher longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT neypatrick longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT hongjeonghee longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT leepaul longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT guptanikhil longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT kimwunjae longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy AT kimisaacyi longitudinalrecoverypatternsofpenilelengthandtheunderexploredbenefitoflongtermphosphodiesterase5inhibitoruseafterradicalprostatectomy |